Latest: FDA Approves New Biosimilar for Oncology Treatment
Neurology

Monitoring Long-Term Efficacy of Migraine Wearable Device Over 3 Years: Alit Stark-Inbar, PhD

by Neurology Live
0 Comments
0 Mins
The corporate vice president of medical information and research at Theranica discussed long-term findings presented at AHS 2025 covering the company’s Nerivio remote electrical neuromodulation device for patients with migraine. [WATCH TIME: 5 minutes]
Tags:
Neurology Live
Author

Neurology Live

Previous Post
BioNTech ends patent fight with mRNA rival CureVac ahead of buyout deal
Next Post
A Personalized Approach: Considerations for Appropriate Biologic Selection in Hidradenitis Suppurativa
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago